Day: June 26, 2024
June 26, 2024, Oslo, Norway: PGS held its Annual General Meeting today. The Annual General Meeting resolved to approve all matters as proposed in the Calling Notice. The minutes from the Annual General Meeting can be downloaded from www.newsweb.no or www.pgs.com.AttachmentGenforsprotokoll-AGM 2024
Reliance Global Group Announces Reverse Stock Split
Written by Customer Service on . Posted in Public Companies.
LAKEWOOD, N.J., June 26, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI; RELIW) (“Reliance”, “we” or the “Company”) today announced that the Company’s Board of Directors approved a 1-for-17 reverse stock split (the “Reverse Stock Split”) of the Company’s common stock (the “Common Stock”) in order to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (Rule 5550(a)(2)). The Company was not required to obtain shareholder approval to effectuate the Reverse Stock Split. The Company filed articles of amendment to the Company’s articles of incorporation, as amended, with the Secretary of State of the State of Florida to effectuate the Reverse Stock Split as of 5:00 p.m. Eastern Time on June 28, 2024. The Common Stock will begin trading on The Nasdaq Capital...
Goldenstone Acquisition Limited. and Infintium Fuel Cell Systems, Inc. Announce Definitive Business Combination Agreement
Written by Customer Service on . Posted in Public Companies.
Infintium’s advanced hydrogen fuel cell technologies for material handling vehicles bring carbon-free and clean power source to major automotive, industrial, and retail companies
Corporate net zero commitments expected to propel hydrogen powered heavy duty truck adoption
Aurora, IL and Greer, SC, June 26, 2024 (GLOBE NEWSWIRE) — Goldenstone Acqusition Limited (“Goldenstone”), (NASDAQ: GDST), a Delaware blank check company, today announced that it and Infintium Fuel Cell Systems, Inc. (“Infintium” or the “Company”), a Greer, South Carolina based hydrogen fuel cell technology provider to some of the world’s largest commercial, industrial and retail companies, have entered into a definitive business combination agreement (the “Business Combination Agreement,” and the transactions contemplated thereunder, collectively, the “Business...
Texas Capital to Open Full-Service, Digital-Forward Financial Center in Southlake, Texas
Written by Customer Service on . Posted in Public Companies.
DALLAS, June 26, 2024 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today announced it will open a new financial center in Southlake, Texas next month. It will be the first location of its kind for the firm, transforming its retail strategy to meet the evolving needs of the clients within the markets it serves across Texas.
The Southlake Financial Center will be located at 1538 East Southlake Boulevard in the heart of the Southlake Town Square alongside State Highway 114. As part of Texas Capital’s firm-wide transformation, the new location will advance the firm’s commitment to delivering relationship-focused, elevated client experiences. The location was designed to complement digital capabilities with the in-person experience that provides access to the firm’s private wealth...
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
Written by Customer Service on . Posted in Public Companies.
Lengthens Patent Exclusivity of Plogosertib until August 2040
BERKELEY HEIGHTS, N.J., June 26, 2024 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the receipt of a notice from the European Patent Office of the intention to grant a patent which includes claims to novel pharmaceutical compositions of plogosertib, a PLK1 inhibitor. Once granted, the European patent will provide exclusivity until August 2040 not including any extensions. The Company is prosecuting patent applications from the same family in other jurisdictions.
“The notice further strengthens the Company’s patent portfolio and attests to the novelty of Cyclacel’s clinical...
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Written by Customer Service on . Posted in Public Companies.
DALLAS, June 26, 2024 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 14,361,113 shares of its common stock at a price to the public of $2.25 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 18,972,221 shares of its common stock at an offering price of $2.249 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered...
Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety
Written by Customer Service on . Posted in Public Companies.
Amplify Bio to complete GLP study of SPC-15 Novel Intranasal Therapeutic
Silo study advances SPC-15 towards first-in-human trial
SARASOTA, FL, June 26, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced that it has awarded a contract to its contract research organization (CRO) partner AmplifyBio for an investigational new drug (IND)-enabling large animal GLP (Good Laboratory Practice) study of its lead asset, SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder (PTSD).
The 4-week GLP study will evaluate a 28-day repeat intranasal dosing with a 14-day recovery. In a recent non-GLP small...
Caisse Française de Financement Local: EMTN 2024-3 Amended&Restated Final Terms
Written by Customer Service on . Posted in Public Companies.
Paris, 26 June 2024 Caisse Française de Financement Local (“Caffil”) has amended the Final Terms dated 1 March 2024 relating to the issue of €20,000,000 3.812 per cent. obligations foncières due 5 March 2064 (ISIN Code: FR001400OGL4) (the “Obligations Foncières”) under its €75,000,000,000 EMTN Programme (the “Amended and Restated Final Terms”). The amendment provides for the correction of the following manifest error in the Final Terms:
Item 21 (ii) entitled “Optional Redemption Amount of each Obligation Foncière” in Part A ofthe Final Terms is deleted and replaced as follows:
(ii)
Optional Redemption Amount of eachObligation Foncière:
EUR 100,000 per Obligation Foncière of EUR 100,000 Specified Denomination
Caffil accepts responsibility for the information included in this notice to the bondholders.
The...
Nuwellis Announces Reverse Stock Split
Written by Customer Service on . Posted in Public Companies.
MINNEAPOLIS, June 26, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, announced today a 1-for-35 reverse split (the “Reverse Stock Split”) of its common stock, par value $0.0001 (the “Common Stock”), effective at 5:00 pm Eastern Time June 27, 2024. Beginning on June 28, 2024, the Company’s Common Stock will trade on The Nasdaq Capital Market on a split-adjusted basis.
At the Company’s annual meeting of stockholders on June 6, 2024, its stockholders approved a proposal to amend the Company’s Fourth Amended and Restated Certificate of Incorporation to effect such a reverse split of the Company’s outstanding Common Stock at a ratio in the range of 1-for-5 to 1-for-70 to be determined at the discretion...
Genius Group to Present at Noble Capital Markets Virtual Equity Conference on June 26, 2024
Written by Customer Service on . Posted in Public Companies.
Singapore, June 26, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, today announced that management has been invited to present at the Noble Capital Markets Virtual Equity Conference, being held June 26-27, 2024.
Peter Ritz, Genius Group’s CRO, is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and will host a virtual presentation as follows:
Noble Capital Markets Virtual Equity Conference
Date: Wednesday, June 26, 2024 Time: 9:00 a.m. Eastern time Registration:https://www.meetmax.com/sched/event_107201/investor_reg_new.html?attendee_role_id=NOBLE_INVESTORAll interested investors are invited to join the online presentation. Please join at least ten minutes before...